Abeona Therapeutics Inc vs Global X MSCI Argentina ETF — how do they compare? Abeona Therapeutics Inc trades at $7.57 (market cap $421.19M), while Global X MSCI Argentina ETF trades at $93. The key difference: Abeona Therapeutics Inc is trading nearer its 52-week high, Global X MSCI Argentina ETF nearer its low. Which is the better fit depends on your goals.
| ABEO | ARGT | |
|---|---|---|
Market Cap | $421.19M | — |
Sector | Health | Broad Market / Factor |
52-Week High | $7.45 | $102.94 |
52-Week Low | $4.17 | $67.55 |
Enterprise Value | $276.10M | — |
Trailing returns across standard periods
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Read more on ABEO →ARGT seeks to provide investment results that correspond to the performance of the MSCI All Argentina 25/50 Index. It offers targeted exposure to some of the largest and most liquid companies operating in Argentina.
Read more on ARGT →